Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Cham, Candace M ^a   Ko, Kichul ^a   Niewold, Timothy B ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; INTERFERON REGULATORY FACTOR 5; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; INTERFERON REGULATORY FACTOR;

AUTOIMMUNITY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; GENE; GENE EXPRESSION; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENETIC SIMILARITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; INDEL MUTATION; IRF5 GENE; NUCLEAR EXPORT SIGNAL; NUCLEAR LOCALIZATION SIGNAL; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; UBIQUITINATION; ANIMAL; AUTOIMMUNE DISEASE; IMMUNOLOGY;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; INTERFERON REGULATORY FACTORS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 84870217929     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/780436     Document Type: Review

References (87)

1. Hochberg M. C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 1997 40 9 1725 2-s2.0-0031229830
2. Alarcón-Segovia D., Alarcón-Riquelme M. E., Cardiel M. H., Caeiro F., Massardo L., Villa A. R., Pons-Estel B. A., Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis and Rheumatism 2005 52 4 1138 1147 2-s2.0-17244373451 10.1002/art.20999 (Pubitemid 40530121)
3. Rhodes B., Vyse T. J., The genetics of SLE: an update in the light of genome-wide association studies. Rheumatology 2008 47 11 1603 1611 2-s2.0-54549093861 10.1093/rheumatology/ken247
4. Tsokos G. C., Systemic lupus erythematosus. The New England Journal of Medicine 2011 365 22 2110 2121
5. Blanco P., Palucka A. K., Gill M., Pascual V., Banchereau J., Induction of dendritic cell differentiation by IFN- α in systemic lupus erythematosus. Science 2001 294 5546 1540 1543 2-s2.0-0035900481 10.1126/science.1064890 (Pubitemid 33063928)
6. Niewold T. B., Clark D. N., Salloum R., Poole B. D., Interferon alpha in systemic lupus erythematosus. Journal of Biomedicine and Biotechnology 2010 2010 8 2-s2.0-77955350698 10.1155/2010/948364 948364
7. Kim T., Kanayama Y., Negoro N., Okamura M., Takeda T., Inoue T., Serum levels of interferons in patients with systemic lupus erythematosus. Clinical and Experimental Immunology 1987 70 3 562 569 2-s2.0-0023601716 (Pubitemid 18013195)
8. Niewold T. B., Hua J., Lehman T. J. A., Harley J. B., Crow M. K., High serum IFN- α activity is a heritable risk factor for systemic lupus erythematosus. Genes and Immunity 2007 8 6 492 502 2-s2.0-34548438559 10.1038/sj.gene.6364408 (Pubitemid 47365615)
9. Weckerle C. E., Franek B. S., Kelly J. A., Kumabe M., Mikolaitis R. A., Green S. L., Utset T. O., Jolly M., James J. A., Harley J. B., Niewold T. B., Network analysis of associations between serum interferon- α activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis and Rheumatism 2011 63 4 1044 1053 2-s2.0-79953677484 10.1002/art.30187
10. Baechler E. C., Batliwalla F. M., Karypis G., Gaffney P. M., Ortmann W. A., Espe K. J., Shark K. B., Grande W. J., Hughes K. M., Kapur V., Gregersen P. K., Behrens T. W., Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proceedings of the National Academy of Sciences of the United States of America 2003 100 5 2610 2615 2-s2.0-0344492212 10.1073/pnas.0337679100 (Pubitemid 36297546)
11. Bennett L., Palucka A. K., Arce E., Cantrell V., Borvak J., Banchereau J., Pascual V., Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. Journal of Experimental Medicine 2003 197 6 711 723 2-s2.0-0037451167 10.1084/jem.20021553 (Pubitemid 36350866)
12. Han G. M., Chen S. L., Shen N., Ye S., Bao C. D., Gu Y. Y., Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes and Immunity 2003 4 3 177 186 2-s2.0-0141986842 10.1038/sj.gene.6363966 (Pubitemid 38967595)
13. Ishii T., Onda H., Tanigawa A., Ohshima S., Fujiwara H., Mima T., Katada Y., Deguchi H., Suemura M., Miyake T., Miyatake K., Kawase I., Zhao H., Tomiyama Y., Saeki Y., Nojima H., Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients. DNA Research 2005 12 6 429 439 2-s2.0-33744939183 10.1093/dnares/ dsi020 (Pubitemid 43843812)
14. Kirou K. A., Lee C., George S., Louca K., Papagiannis I. G., Peterson M. G. E., Ly N., Woodward R. N., Fry K. E., Lau A. Y. H., Prentice J. G., Wohlgemuth J. G., Crow M. K., Coordinate overexpression of interferon- α -induced genes in systemic lupus erythematosus. Arthritis and Rheumatism 2004 50 12 3958 3967 2-s2.0-10444248118 10.1002/art.20798 (Pubitemid 39643944)
15. Ko K., Franek B. S., Marion M., Kaufman K. M., Langefeld C. D., Harley J. B., Genetic ancestry, serum interferon-alpha activity, and autoantibodies in systemic lupus erythematosus. Journal of Rheumatology 2012 39 6 1238 1240
16. Niewold T. B., Adler J. E., Glenn S. B., Lehman T. J. A., Harley J. B., Crow M. K., Age- and sex-related patterns of serum interferon- α activity in lupus families. Arthritis and Rheumatism 2008 58 7 2113 2119 2-s2.0-47249111689 10.1002/art.23619 (Pubitemid 351988103)
17. Ronnblom L. E., Oberg K. E., Alm G. V., Possible induction of systemic lupus erythematosus by interferon α -treatment in a patient with a malignant carcinoid tumour. Journal of Internal Medicine 1990 227 3 207 210 2-s2.0-0025057503 (Pubitemid 20075945)
18. Niewold T. B., Swedler W. I., Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clinical Rheumatology 2005 24 2 178 181 2-s2.0-17544373868 10.1007/s10067-004-1024-2 (Pubitemid 40552976)
19. Niewold T. B., Interferon alpha-induced lupus: proof of principle. Journal of Clinical Rheumatology 2008 14 3 131 132 2-s2.0-48249136616 10.1097/RHU.0b013e318177627d
20. Barnes B. J., Moore P. A., Pitha P. M., Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon α genes. Journal of Biological Chemistry 2001 276 26 23382 23390 2-s2.0-0035968246 10.1074/jbc.M101216200
21. Sigurdsson S., Nordmark G., Göring H. H. H., Lindroos K., Wiman A. C., Sturfeit G., Jönsen A., Rantapää-Dahlqvist S., Möller B., Kere J., Koskenmies S., Widén E., Eloranta M. L., Julkunen H., Kristjansdottir H., Steinsson K., Alm G., Rönnblom L., Syvänen A. C., Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. American Journal of Human Genetics 2005 76 3 528 537 2-s2.0-13844292408 10.1086/428480 (Pubitemid 40250533)
22. Graham R. R., Kozyrev S. V., Baechler E. C., Reddy M. V. P. L., Plenge R. M., Bauer J. W., Ortmann W. A., Koeuth T., Escribano M. F. G., Pons-Estel B., Petri M., Daly M., Gregersen P. K., Martín J., Altshuler D., Behrens T. W., Alarcón-Riquelme M. E., A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nature Genetics 2006 38 5 550 555 2-s2.0-33646368404 10.1038/ng1782
23. Graham R. R., Kyogoku C., Sigurdsson S., Vlasova I. A., Davies L. R. L., Baechler E. C., Plenge R. M., Koeuth T., Ortmann W. A., Hom G., Bauer J. W., Gillett C., Burtt N., Graham D. S. C., Onofrio R., Petri M., Gunnarsson I., Svenungsson E., Rönnblom L., Nordmark G., Gregersen P. K., Moser K., Gaffney P. M., Criswell L. A., Vyse T. J., Syvänen A. C., Bohjanen P. R., Daly M. J., Behrens T. W., Altshuler D., Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proceedings of the National Academy of Sciences of the United States of America 2007 104 16 6758 6763 2-s2.0-34249860408 10.1073/pnas.0701266104 (Pubitemid 47175574)
24. Shin H. D., Sung Y. K., Choi C. B., Lee S. O., Lee H. W., Bae S. C., Replication of the genetic effects of IFN regulatory factor 5 (IRF5) on systemic lupus erythematosus in a Korean population. Arthritis Research and Therapy 2007 9, article R32 2-s2.0-34247628971 10.1186/ar2152 (Pubitemid 46680795)
25. Reddy M. V. P. L., Velázquez-Cruz R., Baca V., Lima G., Granados J., Orozco L., Alarcón-Riquelme M. E., Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans. Human Genetics 2007 121 6 721 727 2-s2.0-34250369117 10.1007/s00439-007-0367-6 (Pubitemid 46916971)
26. Kawasaki A., Kyogoku C., Ohashi J., Miyashita R., Hikami K., Kusaoi M., Tokunaga K., Takasaki Y., Hashimoto H., Behrens T. W., Tsuchiya N., Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms. Arthritis and Rheumatism 2008 58 3 826 834 2-s2.0-40549100665 10.1002/art.23216 (Pubitemid 351364880)
27. Kelly J. A., Kelley J. M., Kaufman K. M., Kilpatrick J., Bruner G. R., Merrill J. T., James J. A., Frank S. G., Reams E., Brown E. E., Gibson A. W., Marion M. C., Langefeld C. D., Li Q. Z., Karp D. R., Wakeland E. K., Petri M., Ramsey-Goldman R., Reveille J. D., Vilá L. M., Alarcón G. S., Kimberly R. P., Harley J. B., Edberg J. C., Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes and Immunity 2008 9 3 187 194 2-s2.0-42549152933 10.1038/gene.2008.4 (Pubitemid 351584185)
28. Sigurdsson S., Göring H. H. H., Kristjansdottir G., Milani L., Nordmark G., Sandling J. K., Eloranta M. L., Feng D., Sangster-Guity N., Gunnarsson I., Svenungsson E., Sturfelt G., Jönsen A., Truedsson L., Barnes B. J., Alm G., Rönnblom L., Syvänen A. C., Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Human Molecular Genetics 2008 17 6 872 881 2-s2.0-40649121122 10.1093/hmg/ddm359 (Pubitemid 351368993)
29. Siu H. O., Yang W., Lau C. S., Chan T. M., Wong R. W. S., Wong W. H. S., Lau Y. L., Alarcon-Riquelme M. E., Association of a haplotype of IRF5 gene with systemic lupus erythematosus in Chinese. Journal of Rheumatology 2008 35 2 360 362 2-s2.0-39549092431 (Pubitemid 351281165)
30. Hom G., Graham R. R., Modrek B., Taylor K. E., Ortmann W., Garnier S., Lee A. T., Chung S. A., Ferreira R. C., Pant P. V. K., Ballinger D. G., Kosoy R., Demirci F. Y., Kamboh M. I., Kao A. H., Tian C., Gunnarsson I., Bengtsson A. A., Rantapää-Dahlqvist S., Petri M., Manzi S., Seldin M. F., Rönnblom L., Syvänen A. C., Criswell L. A., Gregersen P. K., Behrens T. W., Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. New England Journal of Medicine 2008 358 9 900 909 2-s2.0-40049108936 10.1056/NEJMoa0707865 (Pubitemid 351397089)
31. Gateva V., Sandling J. K., Hom G., Taylor K. E., Chung S. A., Sun X., Ortmann W., Kosoy R., Ferreira R. C., Nordmark G., Gunnarsson I., Svenungsson E., Padyukov L., Sturfelt G., Jönsen A., Bengtsson A. A., Rantapää-Dahlqvist S., Baechler E. C., Brown E. E., Alarcón G. S., Edberg J. C., Ramsey-Goldman R., McGwin G., Reveille J. D., Vilá L. M., Kimberly R. P., Manzi S., Petri M. A., Lee A., Gregersen P. K., Seldin M. F., Rönnblom L., Criswell L. A., Syvänen A. C., Behrens T. W., Graham R. R., A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nature Genetics 2009 41 11 1228 1233 2-s2.0-70350650472 10.1038/ng.468
32. Han J. W., Zheng H. F., Cui Y., Sun L. D., Ye D. Q., Hu Z., Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nature Genetics 2009 41 11 1234 1237
33. Jarvinen T. M., Hellquist A., Zucchelli M., Koskenmies S., Panelius J., Hasan T., Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population. Rheumatology 2012 51 1 87 92
34. Nordang G. B., Viken M. K., Amundsen S. S., Sanchez E. S., Flato B., Forre O. T., Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts. Rheumatology 2012 51 4 619 626
35. Nelson N., Marks M. S., Driggers P. H., Ozato K., Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Molecular and Cellular Biology 1993 13 1 588 599 2-s2.0-0027464265 (Pubitemid 23006936)
36. Escalante C. R., Yie J., Thanos D., Aggarwal A. K., Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature 1998 391 6662 103 106 2-s2.0-0031933646 10.1038/34224 (Pubitemid 28079225)
37. Santana-de Anda K., Gomez-Martin D., Diaz-Zamudio M., Alcocer-Varela J., Interferon regulatory factors: beyond the antiviral response and their link to the development of autoimmune pathology. Autoimmunity Reviews 2011 11 2 98 103
38. Sweeney S. E., Targeting interferon regulatory factors to inhibit activation of the type I IFN response: implications for treatment of autoimmune disorders. Cellular Immunology 2011 271 2 342 349
39. Krausgruber T., Blazek K., Smallie T., Alzabin S., Lockstone H., Sahgal N., Hussell T., Feldmann M., Udalova I. A., IRF5 promotes inflammatory macrophage polarization and T H1-TH17 responses. Nature Immunology 2011 12 3 231 238 2-s2.0-79951671510 10.1038/ni.1990
40. Kozyrev S. V., Alarcon-Riquelme M. E., The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity 2007 40 8 591 601 2-s2.0-37349039478 10.1080/08916930701510905 (Pubitemid 350302184)
41. Barnes B. J., Kellum M. J., Field A. E., Pitha P. M., Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Molecular and Cellular Biology 2002 22 16 5721 5740 2-s2.0-0036311933 10.1128/MCB.22.16.5721-5740.2002 (Pubitemid 34815822)
42. Taniguchi T., Ogasawara K., Takaoka A., Tanaka N., IRF family of transcription factors as regulators of host defense. Annual Review of Immunology 2001 19 623 655 2-s2.0-0035061538 10.1146/annurev.immunol.19.1.623 (Pubitemid 32368048)
43. Kawasaki T., Kawai T., Akira S., Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity. Immunological Reviews 2011 243 1 61 73
44. Cheng T. F., Brzostek S., Ando O., Van Scoy S., Kumar K. P., Reich N. C., Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection. Journal of Immunology 2006 176 12 7462 7470 2-s2.0-33744906762 (Pubitemid 43849049)
45. Schoenemeyer A., Barnes B. J., Mancl M. E., Latz E., Goutagny N., Pitha P. M., Fitzgerald K. A., Golenbock D. T., The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. Journal of Biological Chemistry 2005 280 17 17005 17012 2-s2.0-20444380445 10.1074/jbc.M412584200 (Pubitemid 41389162)
46. Takaoka A., Yanai H., Kondo S., Duncan G., Negishi H., Mizutani T., Kano S. I., Honda K., Ohba Y., Mak T. W., Taniguchi T., Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005 434 7030 243 249 2-s2.0-15044345461 10.1038/nature03308 (Pubitemid 40388058)
47. Kawai T., Sato S., Ishii K. J., Coban C., Hemmi H., Yamamoto M., Terai K., Matsuda M., Inoue J. I., Uematsu S., Takeuchi O., Akira S., Interferon- α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nature Immunology 2004 5 10 1061 1068 2-s2.0-5444274514 10.1038/ni1118 (Pubitemid 41057726)
48. Balkhi M. Y., Fitzgerald K. A., Pitha P. M., Functional regulation of MyD88-activated interferon regulatory factor 5 by K63-linked polyubiquitination. Molecular and Cellular Biology 2008 28 24 7296 7308 2-s2.0-57349121051 10.1128/MCB.00662-08
49. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., Slaughter C., Pickart C., Chen Z. J., Activation of the I κ b kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000 103 2 351 361 2-s2.0-0034644474
50. Feng D., Sangster-Guity N., Stone R., Korczeniewska J., Mancl M. E., Fitzgerald-Bocarsly P., Barnes B. J., Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression. Journal of Immunology 2010 185 10 6003 6012 2-s2.0-78650637976 10.4049/jimmunol.1000482
51. Baccala R., Hoebe K., Kono D. H., Beutler B., Theofilopoulos A. N., TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nature Medicine 2007 13 5 543 551 2-s2.0-34249707811 10.1038/nm1590 (Pubitemid 46828489)
52. Au W. C., Yeow W. S., Pitha P. M., Analysis of functional domains of interferon regulatory factor 7 and its association with IRF-3. Virology 2001 280 2 273 282 2-s2.0-0035866330 10.1006/viro.2000.0782 (Pubitemid 34165357)
53. Lin R., Mamane Y., Hiscott J., Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Molecular and Cellular Biology 1999 19 4 2465 2474 2-s2.0-0032915860 (Pubitemid 29144490)
54. Chang Foreman H. C., Van Scoy S., Cheng T. F., Reich N. C., Activation of interferon regulatory factor 5 by site specific phosphorylation. PloS ONE 2012 7 3 e33098
55. Chen W., Lam S. S., Srinath H., Jiang Z., Correia J. J., Schiffer C. A., Fitzgerald K. A., Lin K., Royer W. E., Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Nature Structural and Molecular Biology 2008 15 11 1213 1220 2-s2.0-55549138004 10.1038/nsmb.1496
56. Lin R., Yang L., Arguello M., Penafuerte C., Hiscott J., A CRM1-dependent nuclear export pathway is involved in the regulation of IRF-5 subcellular localization. Journal of Biological Chemistry 2005 280 4 3088 3095 2-s2.0-13244281709 10.1074/jbc.M408452200 (Pubitemid 40189419)
57. Barnes B. J., Field A. E., Pitha-Rowe P. M., Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFNA enhanceosome in vivo and transcriptional activity of IFNA genes. Journal of Biological Chemistry 2003 278 19 16630 16641 2-s2.0-0038608016 10.1074/jbc.M212609200 (Pubitemid 36799526)
58. Pickart C. M., Fushman D., Polyubiquitin chains: polymeric protein signals. Current Opinion in Chemical Biology 2004 8 6 610 616 2-s2.0-8844237615 10.1016/j.cbpa.2004.09.009 (Pubitemid 39535722)
59. Hutti J. E., Turk B. E., Asara J. M., Ma A., Cantley L. C., Abbott D. W., I κ B kinase β phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF- κ B pathway. Molecular and Cellular Biology 2007 27 21 7451 7461 2-s2.0-35648958721 10.1128/MCB.01101-07 (Pubitemid 350033652)
60. Mancl M. E., Hu G., Sangster-Guity N., Olshalsky S. L., Hoops K., Fitzgerald-Bocarsly P., Pitha P. M., Pinder K., Barnes B. J., Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms: multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. Journal of Biological Chemistry 2005 280 22 21078 21090 2-s2.0-20444368020 10.1074/jbc.M500543200 (Pubitemid 40805667)
61. Nusinzon I., Horvath C. M., Histone deacetylases as transcriptional activators? Role reversal in inducible gene regulation. Science's STKE 2005 2005 296, article re11 2-s2.0-30944470262
62. Caillaud A., Prakash A., Smith E., Masumi A., Hovanessian A. G., Levy D. E., Marié I., Acetylation of interferon regulatory factor-7 by p300/CREB-binding protein (CBP)-associated factor (PCAF) impairs its DNA binding. Journal of Biological Chemistry 2002 277 51 49417 49421 2-s2.0-0347298773 10.1074/jbc.M207484200 (Pubitemid 36014375)
63. Masumi A., Yamakawa Y., Fukazawa H., Ozato K., Komuro K., Interferon regulatory factor-2 regulates cell growth through its acetylation. Journal of Biological Chemistry 2003 278 28 25401 25407 2-s2.0-0038491558 10.1074/jbc.M213037200 (Pubitemid 36835290)
64. Niewold T. B., Kelly J. A., Kariuki S. N., Franek B. S., Kumar A. A., Kaufman K. M., IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Annals of the Rheumatic Diseases 2012 71 3 463 468
65. Kozyrev S. V., Lewén S., Reddy P. M. V. L., Pons-Estel B., Witte T., Junker P., Laustrup H., Gutiérrez C., Suárez A., González-Escribano M. F., Martín J., Alarcón-Riquelme M. E., Scherbarth H. R., Marino P. C., Motta E. L., Gamron S., Drenkard C., Menso E., Allievi A., Tate G. A., Presas J. L., Palatnik S. A., Abdala M., Bearzotti M., Alvarellos A., Caeiro F., Bertoli A., Paira S., Roverano S., Graf C. E., Bertero E., Caprarulo C., Buchanan G., Guillerón C., Grimaudo S., Manni J., Catoggio L. J., Soriano E. R., Santos C. D., Prigione C., Ramos F. A., Navarro S. M., Berbotto G. A., Jorfen M., Romero E. J., Garcia M. A., Marcos J. C., Marcos A. I., Perandones C. E., Eimon A., Battagliotti C. G., Armadi-Simab K., Gross W. L., Gromnica-IhIe E., Peter H. H., Manger K., Schnarr S., Zeidler H., Schmidt R. E., Ortego N., De Ramón E., Jiménez-Alonso J., Sánchez-Román J., López-Nevot M. A., Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis and Rheumatism 2007 56 4 1234 1241 2-s2.0-34247254495 10.1002/art.22497 (Pubitemid 46608648)
66. Graham D. S. C., Manku H., Wagner S., Reid J., Timms K., Gutin A., Lanchbury J. S., Vyse T. J., Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation. Human Molecular Genetics 2007 16 6 579 591 2-s2.0-34247125683 10.1093/hmg/ddl469 (Pubitemid 46585660)
67. Wen F., Ellingson S. M., Kyogoku C., Peterson E. J., Gaffney P. M., Exon 6 variants carried on systemic lupus erythematosus (SLE) risk haplotypes modulate IRF5 function. Autoimmunity 2011 44 2 82 89 2-s2.0-79551560629 10.3109/08916934.2010.491842
68. Niewold T. B., Kelly J. A., Flesch M. H., Espinoza L. R., Harley J. B., Crow M. K., Association of the IRF5 risk haplotype with high serum interferon- α activity in systemic lupus erythematosus patients. Arthritis and Rheumatism 2008 58 8 2481 2487 2-s2.0-49449104525 10.1002/art.23613
69. Feng D., Stone R. C., Eloranta M. L., Sangster-Guity N., Nordmark G., Sigurdsson S., Wang C., Alm G., Syvänen A. C., Rönnblom L., Barnes B. J., Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus. Arthritis and Rheumatism 2010 62 2 562 573 2-s2.0-75749153301 10.1002/art.27223
70. Rullo O. J., Woo J. M. P., Wu H., Hoftman A. D. C., Maranian P., Brahn B. A., McCurdy D., Cantor R. M., Tsao B. P., Association of IRF5 polymorphisms with activation of the interferon α pathway. Annals of the Rheumatic Diseases 2010 69 3 611 617 2-s2.0-77949435272 10.1136/ard.2009.118315
71. -/- mouse models of systemic lupus erythematosus. Journal of Immunology 2010 184 2 796 806 2-s2.0-76249125968 10.4049/jimmunol.0901748
72. Savitsky D. A., Yanai H., Tamura T., Taniguchi T., Honda K., Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proceedings of the National Academy of Sciences of the United States of America 2010 107 22 10154 10159 2-s2.0-77953368347 10.1073/pnas.1005599107
73. Lien C., Fang C. M., Huso D., Livak F., Lu R., Pitha P. M., Critical role of IRF-5 in regulation of B-cell differentiation. Proceedings of the National Academy of Sciences of the United States of America 2010 107 10 4664 4668 2-s2.0-77949518633 10.1073/pnas.0911193107
74. Niewold T. B., Rivera T. L., Buyon J. P., Crow M. K., Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus. Arthritis and Rheumatism 2008 58 2 541 546 2-s2.0-39749158486 10.1002/art.23191 (Pubitemid 351294888)
75. Cherian T. S., Kariuki S. N., Franek B. S., Buyon J. P., Clancy R. M., Niewold T. B., IRF5 SLE-risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in neonatal lupus mothers. Arthritis and Rheumatism 2012 64 10 3383 3387
76. Salloum R., Niewold T. B., Interferon regulatory factors in human lupus pathogenesis. Translational Research 2011 157 6 326 331 2-s2.0-79956141306 10.1016/j.trsl.2011.01.006
77. Robinson T., Kariuki S. N., Franek B. S., Kumabe M., Kumar A. A., Badaracco M., Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN- α and serologic autoimmunity in lupus patients. Journal of Immunology 2011 187 3 1298 1303
78. Pothlichet J., Niewold T. B., Vitour D., Solhonne B., Crow M. K., Si-Tahar M., A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients. EMBO Molecular Medicine 2011 3 3 142 152 2-s2.0-79952094197 10.1002/emmm.201000120
79. Salloum R., Franek B. S., Kariuki S. N., Rhee L., Mikolaitis R. A., Jolly M., Utset T. O., Niewold T. B., Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon- α activity in lupus patients. Arthritis and Rheumatism 2010 62 2 553 561 2-s2.0-75749110600 10.1002/art.27182
80. Agik S., Franek B. S., Kumar A. A., Kumabe M., Utset T. O., Mikolaitis R. A., The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes. Journal of Immunology 2012 39 1 73 78
81. Niewold T. B., Interferon alpha as a primary pathogenic factor in human lupus. Journal of Interferon & Cytokine Research 2011 31 12 887 892
82. Kariuki S. N., Franek B. S., Kumar A. A., Arrington J., Mikolaitis R. A., Utset T. O., Jolly M., Crow M. K., Skol A. D., Niewold T. B., Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus. Arthritis Research and Therapy 2010 12 4, article R151 2-s2.0-77954877255 10.1186/ar3101
83. Deng Y., Tsao B. P., Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nature Reviews Rheumatology 2010 6 12 683 692 2-s2.0-78649830454 10.1038/nrrheum.2010.176
84. Garcia-Romo G. S., Caielli S., Vega B., Connolly J., Allantaz F., Xu Z., Punaro M., Baisch J., Guiducci C., Coffman R. L., Barrat F. J., Banchereau J., Pascual V., Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Science Translational Medicine 2011 3 73 2-s2.0-79952476762 10.1126/scitranslmed.3001201 73ra20
85. Lande R., Ganguly D., Facchinetti V., Frasca L., Conrad C., Gregorio J., Meller S., Chamilos G., Sebasigari R., Riccieri V., Bassett R., Amuro H., Fukuhara S., Ito T., Liu Y. J., Gilliet M., Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Science Translational Medicine 2011 3 73 2-s2.0-79952468782 10.1126/scitranslmed.3001180 73ra19
86. Hennessy E. J., Parker A. E., O'Neill L. A. J., Targeting Toll-like receptors: emerging therapeutics? Nature Reviews Drug Discovery 2010 9 4 293 307 2-s2.0-77950542752 10.1038/nrd3203
87. Lichtman E. I., Helfgott S. M., Kriegel M. A., Emerging therapies for systemic lupus erythematosus-focus on targeting interferon-alpha. Clinical Immunology 2012 143 3 210 221